The store will not work correctly when cookies are disabled.
(3-bromopyrazolo[1,5-a]pyridin-2-yl)(4-(2,4-difluorophenethyl)piperazin-1-yl)methanone
ID: ALA1957801
PubChem CID: 57391358
Max Phase: Preclinical
Molecular Formula: C20H19BrF2N4O
Molecular Weight: 449.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1nn2ccccc2c1Br)N1CCN(CCc2ccc(F)cc2F)CC1
Standard InChI: InChI=1S/C20H19BrF2N4O/c21-18-17-3-1-2-7-27(17)24-19(18)20(28)26-11-9-25(10-12-26)8-6-14-4-5-15(22)13-16(14)23/h1-5,7,13H,6,8-12H2
Standard InChI Key: CELPFHKOYOVBDS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
18.0850 2.3044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0850 1.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7971 1.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5092 1.4793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5092 2.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7971 2.7211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3693 2.7149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3668 3.5399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6559 2.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2231 1.0657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9382 1.4772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6522 1.0637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6480 0.2406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3612 -0.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0772 0.2387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0758 1.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3621 1.4777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3593 2.3028 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.7917 -0.1739 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.8973 2.6352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5681 1.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7617 1.3071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3502 2.0197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5292 2.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1188 1.3057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5353 0.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3549 0.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1816 0.9294 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
1 7 1 0
14 15 2 0
1 2 1 0
15 16 1 0
7 8 2 0
16 17 2 0
17 12 1 0
1 6 1 0
17 18 1 0
7 9 1 0
15 19 1 0
9 20 2 0
2 3 1 0
4 10 1 0
20 23 1 0
22 21 2 0
21 9 1 0
3 4 1 0
10 11 1 0
22 23 1 0
4 5 1 0
23 24 1 0
11 12 1 0
24 25 2 0
5 6 1 0
25 26 1 0
12 13 2 0
26 27 2 0
27 22 1 0
21 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 449.30 | Molecular Weight (Monoisotopic): 448.0710 | AlogP: 3.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 40.85 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.09 | CX LogP: 4.10 | CX LogD: 4.08 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.61 | Np Likeness Score: -2.05 |
References
1. Xiong Y, Ullman B, Choi JS, Cherrier M, Strah-Pleynet S, Decaire M, Feichtinger K, Frazer JM, Yoon WH, Whelan K, Sanabria EK, Grottick AJ, Al-Shamma H, Semple G.. (2012) Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia., 22 (5): [PMID:22325948] [10.1016/j.bmcl.2012.01.080] |